These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17004700)

  • 41. Binding response: a descriptor for selecting ligand binding site on protein surfaces.
    Zhong S; MacKerell AD
    J Chem Inf Model; 2007; 47(6):2303-15. PubMed ID: 17900106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of binding mode prediction with a cascadic stochastic tunneling method.
    Fischer B; Basili S; Merlitz H; Wenzel W
    Proteins; 2007 Jul; 68(1):195-204. PubMed ID: 17427957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery.
    Ghose AK; Herbertz T; Pippin DA; Salvino JM; Mallamo JP
    J Med Chem; 2008 Sep; 51(17):5149-71. PubMed ID: 18710211
    [No Abstract]   [Full Text] [Related]  

  • 44. Steering protein-ligand docking with quantitative NMR chemical shift perturbations.
    González-Ruiz D; Gohlke H
    J Chem Inf Model; 2009 Oct; 49(10):2260-71. PubMed ID: 19795907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homology-based modelling of targets for rational drug design.
    Wieman H; Tøndel K; Anderssen E; Drabløs F
    Mini Rev Med Chem; 2004 Sep; 4(7):793-804. PubMed ID: 15379646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.
    Favia AD; Nobeli I; Glaser F; Thornton JM
    J Mol Biol; 2008 Jan; 375(3):855-74. PubMed ID: 18036612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Position specific interaction dependent scoring technique for virtual screening based on weighted protein--ligand interaction fingerprint profiles.
    Nandigam RK; Kim S; Singh J; Chuaqui C
    J Chem Inf Model; 2009 May; 49(5):1185-92. PubMed ID: 19415918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.
    Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2648-56. PubMed ID: 18410085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supervised scoring models with docked ligand conformations for structure-based virtual screening.
    Teramoto R; Fukunishi H
    J Chem Inf Model; 2007; 47(5):1858-67. PubMed ID: 17685604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
    Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling of metal interaction geometries for protein-ligand docking.
    Seebeck B; Reulecke I; Kämper A; Rarey M
    Proteins; 2008 May; 71(3):1237-54. PubMed ID: 18041759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A flexible approach to induced fit docking.
    Nabuurs SB; Wagener M; de Vlieg J
    J Med Chem; 2007 Dec; 50(26):6507-18. PubMed ID: 18031000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated prediction of ligand-binding sites in proteins.
    Harris R; Olson AJ; Goodsell DS
    Proteins; 2008 Mar; 70(4):1506-17. PubMed ID: 17910060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation and use of the MM-PBSA approach for drug discovery.
    Kuhn B; Gerber P; Schulz-Gasch T; Stahl M
    J Med Chem; 2005 Jun; 48(12):4040-8. PubMed ID: 15943477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
    Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
    J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.